Crossref
Immune Cells and Risk of Cervical Cancer: Evidence from a Mendelian Randomization Study
Clinical Laboratory · 2026 · 72 (04/2026)
DOI: 10.7754/clin.lab.2025.250552 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Laboratory, 2026. Verfasst von Lin Guo und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Uterine Cervical NeoplasmsMendelian Randomization AnalysisPolymorphism, Single NucleotideHumansFemaleGenetic Predisposition to DiseaseRisk Factors
Zitieren
APA
Guo, L., Yuan, X., Zhou, Y., Zhang, D., Hui, H., & Zhang, Y. (2026). Immune Cells and Risk of Cervical Cancer: Evidence from a Mendelian Randomization Study. Clinical Laboratory, 72(04/2026). https://doi.org/10.7754/clin.lab.2025.250552
Vancouver
Guo L, Yuan X, Zhou Y, Zhang D, Hui H, Zhang Y. Immune Cells and Risk of Cervical Cancer: Evidence from a Mendelian Randomization Study. Clinical Laboratory. 2026;72(04/2026). doi:10.7754/clin.lab.2025.250552
BibTeX
@article{Guo2026,
author = {Guo, Lin and Yuan, Xi and Zhou, Yun and Zhang, Da and Hui, Hui and Zhang, Yan},
title = {Immune Cells and Risk of Cervical Cancer: Evidence from a Mendelian Randomization Study},
journal = {Clinical Laboratory},
year = {2026},
volume = {72},
number = {04/2026},
doi = {10.7754/clin.lab.2025.250552}
}
EUVIMED